ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

AVXL Anavex Life Sciences Corporation

3.44
0.05 (1.47%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Anavex Life Sciences Corporation AVXL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.05 1.47% 3.44 08:48:08
개장가 저가 고가 종가 전일 종가
3.40 3.37 3.48 3.44 3.39
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
26/04/202418:45PRNUSMay 13, 2024 Deadline: Contact The Gross Law Firm to Join..
19/04/202418:45PRNUSContact The Gross Law Firm by May 13, 2024 Deadline to Join..
16/04/202418:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
12/04/202418:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
11/04/202420:30GLOBEAnavex Life Sciences to Present at the Noble Capital Markets..
09/04/202418:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
05/04/202418:45PRNUSAnavex Life Sciences Corporation Class Action: The Gross Law..
02/04/202418:45PRNUSShareholders that lost money on Anavex Life Sciences..
29/03/202418:45PRNUSLost Money on Anavex Life Sciences Corporation(AVXL)? Join..
26/03/202418:45PRNUSInvestors who lost money on Anavex Life Sciences..
25/03/202420:30GLOBEAnavex Life Sciences to Present at the 23rd Annual Needham..
22/03/202418:45PRNUSAVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life..
18/03/202420:30GLOBEAnavex Life Sciences Initiates Placebo-Controlled U.S. Phase..
26/02/202421:30GLOBEAnavex Life Sciences to Present at the 44th Annual TD Cowen..
23/02/202420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202420:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202420:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/02/202421:30GLOBEAnavex Life Sciences Reports Fiscal 2024 First Quarter..
01/02/202421:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 First Quarter..
26/01/202407:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/01/202421:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
16/01/202421:30GLOBEAnavex Life Sciences Announces U.S. Phase 2 Clinical Trial..
13/01/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202421:30GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
03/01/202421:30GLOBEAnavex to Present at the 42nd Annual J.P. Morgan Healthcare..
02/01/202422:00GLOBEAnavex Life Sciences Provides an Update on Rett Syndrome..
20/12/202321:30GLOBEAnavex Announces First Entire Clinical Gene Pathway Data of..
19/12/202321:30GLOBEAnavex Received Agreement from the Committee for Medicinal..
28/11/202306:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/11/202322:00GLOBEAnavex Life Sciences Reports Fiscal 2023 Year End Financial..
27/11/202320:29IHMARKETNEWSMonday’s Wall Street Highlights: Walmart, Disney, Lloyds..
24/11/202322:00GLOBEAnavex Life Sciences to Announce Fiscal 2023 Year End..
22/11/202322:00GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
20/11/202322:00GLOBEAnavex Initiates Regulatory Submission of Oral Blarcamesine..
06/11/202322:00GLOBEAnavex Life Sciences Appoints Senior VP of Regulatory..
25/10/202321:00GLOBEAnavex Life Sciences Reports New Publication in Scientific..
14/09/202320:30GLOBEAnavex’s Phase 2b/3 Trial of Blarcamesine (ANAVEX®2-73) in..
12/09/202320:30GLOBEAnavex Announces Appointment of Dr. Marwan N Sabbagh, MD as..
09/08/202305:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202320:30GLOBEAnavex Life Sciences Reports Fiscal 2023 Third Quarter..
07/08/202320:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
02/08/202320:30GLOBEAnavex Life Sciences to Present at the BTIG Virtual..
01/08/202320:30GLOBEAnavex Life Sciences to Announce Fiscal 2023 Third Quarter..
28/06/202320:30GLOBELong-term Clinical Study Demonstrates Disease Modifying..
27/06/202320:30GLOBEAnavex Life Sciences and Partex Group Announce Strategic..
20/06/202320:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 4th..
15/06/202320:30GLOBEANAVEX®2-73 (blarcamesine) Receives Compassionate Use..

최근 히스토리

Delayed Upgrade Clock